|
|
||||||||||
|
J Am Coll Cardiol, 2004; 43:194-199, doi:10.1016/j.jacc.2003.09.029 © 2004 by the American College of Cardiology Foundation |


* Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Department of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Manuscript received March 4, 2003; revised manuscript received July 23, 2003, accepted September 9, 2003.
* Reprint requests and correspondence: Dr. Raymond J. Gibbons, Nuclear Cardiology, Charlton 2, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
gibbons.raymond{at}mayo.edu
| Abstract |
|---|
|
|
|---|
BACKGROUND: Current American College of Cardiology/American Heart Association guidelines recommend using a standard exercise test without imaging as the initial test in patients who have an interpretable electrocardiogram and are able to exercise.
METHODS: We studied 1,461 symptomatic patients with low-risk Duke treadmill scores (
5) who underwent myocardial perfusion imaging. The CS was derived by assigning one point to each of the following variables: typical angina, history of myocardial infarction, diabetes, insulin use, male gender, and each decade of age over 40 years. A CS cutoff
5 or <5 was used to categorize patients as high risk (n = 303 [21%]) or low risk (n = 1,158 [79%]). Perfusion scans were categorized as low, intermediate, or high risk on the basis of the global stress score (GSS).
RESULTS: High-risk scans were more common in patients with a high-risk CS (26.4% vs. 9.5%, p < 0.0001). The CS and GSS were significant independent predictors of cardiac death. However, in patients with a low CS, seven-year cardiac survival was excellent, regardless of the GSS (99% for normal scans, 99% for mildly abnormal scans, and 99% for severely abnormal scans). In contrast, patients with a high CS had a lower seven-year survival rate (92%), which varied with GSS (94% for normal scans, 94% for mildly abnormal scans, and 84% for severely abnormal scans; p < 0.001).
CONCLUSIONS: In symptomatic patients with low-risk Duke treadmill scores and low clinical risk, myocardial perfusion imaging is of limited prognostic value. In patients with low-risk Duke treadmill scores and high clinical risk, annual cardiac mortality (>1%) is not low, and myocardial perfusion imaging has independent prognostic value.
| ||||||||||||||||||||
The purpose of this study was to investigate whether a simple clinical score (CS), derived from commonly used clinical variables, could be applied to symptomatic patients with low-risk treadmill scores to identify the small cohort of high-risk patients likely to yield prognostic information from the nuclear scan. We hypothesized that perfusion imaging would have incremental value only in the group whose clinical characteristics put them at higher risk.
| Methods |
|---|
|
|
|---|
Exercise testing.
All patients underwent standard symptom-limited treadmill testing using the Bruce, modified Bruce, or Naughton protocol. Near peak exercise, 3 to 4 mCi of thallium-201 was injected, and the patient exercised for an additional minute, after which the single-photon emission computed tomography (SPECT) was initiated. Redistribution images were obtained 4 h later. For patients who underwent the test after January 1, 1990, an additional 1.0 to 1.5 mCi was injected 30 min before the redistribution images. The magnitude of horizontal or downsloping ST-segment depression, treadmill angina index (no angina = 0; angina during test = 1; test stopped due to angina = 2), and exercise duration was recorded. For those who exercised using the Naughton or Bruce protocol, a conversion factor was applied to the exercise duration to equate the exercise duration with the Bruce protocol (6). The Duke treadmill score was calculated for each patient as follows: exercise time (Bruce protocol) (5 x maximum ST-segment deviation) (4 x angina index). Patients were classified as low risk, based on the Duke classification, with a score of
5 (3).
Perfusion imaging. Stress perfusion images were obtained 10 min after completion of exercise, and redistribution images were obtained 4 h later. Anterior planar images were first obtained (30% window centered at 68 to 80 keV and 20% window centered at 167 keV), followed by the SPECT acquisition using a 64 x 64 matrix of 30 views at 40 s/view. Imaging with SPECT was performed with a large field-of-view camera (Elscint 409, Haifa, Israel) equipped with an all-purpose collimator. After filtered back-projection, the images were reconstructed to obtain the short-axis, vertical, and horizontal long-axis images.
Interpretation of SPECT images. The images were scored using a five-point scoring system by the consensus of two experienced observers. The short-axis slices were divided into 14 segments corresponding to the anterior, lateral, septal, and inferior walls at the apex, mid, and basal levels of the left ventricle. At the mid and basal levels of the left ventricle, the septum was further divided into anterior and inferior septal walls (7). The five-point scoring used to grade each segment was as follows: 0 = absent perfusion; 1 = severe hypoperfusion; 2 = moderate hypoperfusion; 3 = mild hypoperfusion; and 4 = normal perfusion. A fixed defect was considered present if the degree of hypoperfusion was at least moderate and equal on both rest and stress images. A score of 3 on both rest and stress images was considered to represent an attenuation artifact. An increase of >1 grade on the delayed images was considered a reversible defect. Defects in the short-axis slices were confirmed by the other two planes.
Scintigraphic indexes. Nuclear variables were defined using the five-point scoring system. A global stress score (GSS) was obtained by adding the scores on all the stress short-axis images. A global rest score (GRS) was obtained by adding the scores of all the redistribution short-axis images. A global difference score (GDS) was obtained by subtracting GSS from GRS. The maximum that could be obtained for a completely normal set of images was 56 (14 x 4). A score of 53 to 56 was defined as low risk (normal or mildly abnormal), a score of 48 to 52 as intermediate risk (moderately abnormal), and a score of <48 as high risk (severely abnormal). This classification of scores was defined prospectively, based on previous work from Cedars Sinai (2,8).
Clinical score. Hubbard et al. (9) developed the CS retrospectively in a population undergoing evaluation for CAD as a predictor of three-vessel or left main disease. A simple five-point scoring system was developed after consideration of 16 clinical and ECG variables. The variables included in the five-point scoring were male gender, history of MI (clinical event and Q waves on ECG), diabetes, insulin use, and typical angina. This score was an accurate predictor of severe CAD in different age groups. Additional points can be assigned to age, with 1 point for age 40 to 49 years, 2 points for age 50 to 59 years, 3 points for age 60 to 69 years, 4 points for age 70 to 79 years, and 5 points for age >80 years. A male >80 years old with typical angina, a history of MI, and diabetes requiring insulin would receive the maximum of 10 points.
In a prospective study of 2,255 patients, a score
5 identified patients with a higher risk of adverse events (10). Therefore, this cutoff value was used in this study.
Patient follow-up. Personnel blinded to the results of the nuclear study conducted the follow-up by telephone interviews and chart review. Hard events were defined as cardiac death (confirmed by death certificate or medical records) or nonfatal MI (documented by history, ECG changes, and cardiac enzymes). Late revascularization was defined as percutaneous intervention or coronary artery bypass grafting more than three months after the stress test. Follow-up was 99% complete at a mean of 7 ± 1 year.
Statistical analysis. The end points analyzed by the Kaplan-Meier method were: 1) cardiac survival (patients with noncardiac death or revascularization were censored); 2) cardiac survival free of nonfatal MI (patients with noncardiac death or revascularization were censored); and 3) cardiac survival free of nonfatal MI and late revascularization (patients with noncardiac death or revascularization within three months of the thallium study were censored). The association between the CS and GSS and each of these end points, during the entire follow-up period, was evaluated by Cox proportional hazards analysis on both a univariate and bivariate (each variable adjusted for the other) basis. The GSS was selected prospectively as the single nuclear variable to be included in the analysis, based on previous studies (9,11). We tested the proportional hazards assumption by including the product of GSS with time and CS with time in the analysis. The proportional hazards assumption was confirmed for CS. There was a modest time dependence of the hazard ratio for GSS, which achieved significance only for the end point of cardiac survival free of nonfatal MI, and was likely of limited clinical significance. Annual event rates were calculated by dividing the event rate over the follow-up period of seven years by seven.
Each of the three GSS groups described earlier was further subdivided by a CS of <5 or
5, thus creating a total of six risk groups. Group comparisons for the three end points were made by using the log-rank test. Statistical significance was defined as p < 0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Clinical implications. The ACC/AHA guidelines recommend the treadmill test as the first step in patients with interpretable baseline ECGs who are able to exercise, with the exception of those who have undergone revascularization (1). Our study group with low-risk treadmill scores had a very low seven-year cardiac mortality rate of 2% (annual mortality 0.28%). The performance of nuclear imaging in all of these patients after treadmill testing, to identify a few higher risk individuals, does not appear to be efficient. However, those patients with a high-risk CS and low-risk treadmill score are candidates for perfusion imaging, as their seven-year mortality rate is 8% (annual mortality 1.1%), and they can be further risk-stratified by perfusion imaging.
Our results further suggest the possibility that clinical risk (as reflected by the CS) should have a role in the selection of the initial diagnostic test. A CS <5 mandates only a regular exercise treadmill test in patients who can exercise and have an interpretable baseline ECG. If such patients have a low-risk treadmill score, they have an annual cardiac mortality rate <0.25%, and perfusion imaging does not provide enough additional information to justify its added cost. However, in patients with a CS
5, a low-risk treadmill score would still imply an annual cardiac mortality rate of 1.1%. Unless the physician and patient are willing to accept this level of risk, exercise perfusion imaging may be a more appropriate initial test in such patients, as it can better risk-stratify the patient and avoid the inefficiency of two tests. However, our study was not designed to address this issue, which would require consideration of all patients with a high CS, not just those with a low-risk treadmill score.
Role of CS. The CS initially developed by Hubbard et al. (9) paralleled efforts by Pryor et al. (12), the Coronary Artery Surgery Study (CASS) (13) investigators, and others (1417) to develop a clinical model to predict disease severity and prognosis in patients with CAD. Hubbard et al. (9) demonstrated that the probability of severe CAD increased as a function of the CS. This study utilizes the CS as a measure of pretest probability of severe CAD (and of adverse outcomes) in an overall low-risk population. The score clearly identifies a higher risk subgroup (even in this low-risk population) that merits a more aggressive diagnostic approach with perfusion imaging.
Comparison with previous studies. This is the first study to focus specifically on perfusion imaging in patients with low-risk treadmill scores. Using the Duke treadmill score, Mark et al. (3) classified 62% of 613 outpatients as low risk, with an annual mortality rate of 0.25%. However, this group is heterogeneous. In our study, 21% of this population had a high-risk CS and an annual cardiac mortality rate of 1.1%.
Our results are consistent with previous studies (11,18,19) that have examined the incremental value of exercise perfusion imaging in the risk stratification of patients with a normal ECG (and therefore intrinsically at low risk). In these studies, clinical variables were prognostically important, independent of the exercise ECG.
Our results are also consistent with Hachamovitch et al. (2), who reported the incremental value of perfusion imaging in a population with low-risk Duke treadmill scores. In their study, the hard event rate (including cardiac death and MI) increased as a function of scan results (p < 0.05 across scan results). Their subgroup with high-risk scans comprised 51 patients of the total of 926 (5.5%); among these patients, there were four hard events occurring over a period of 1.5 years. In comparison, our study group had a higher prevalence of high-risk scans (12.9%), which may be attributable in part to the inclusion of patients with previous MIs. The total number of hard events among the patients with high-risk scans, 19, in our study was higher, reflecting the larger subgroup and longer follow-up, but the event rates were not significantly different.
A later study by Hachamovitch et al. (20) was restricted to patients with normal resting ECGs. The incremental value of perfusion imaging was greatest (and most cost-effective) in patients with an intermediate to high pretest likelihood of CAD and an intermediate to high post-test likelihood of CAD. The prevalence of high-risk scan (16%) and hard events, 10, in patients with low-risk treadmill scores was closer to that in the current study.
Study limitations. These results are from a symptomatic patient population seen in a tertiary care setting. The applicability of these results to asymptomatic patients or other settings needs to be confirmed. The results of this study should not be applied to the patients in whom the Duke treadmill score cannot be calculated or in whom it has not been validated. The prevalence of diabetes in our population was modest (8%) and lower than the prevalence we reported in other studies, suggesting that diabetics are less likely to have low-risk Duke treadmill scores. Further studies are needed in diabetics.
The cutoff value for the CS was identified by post hoc analysis from a previous study and needs to be validated in other groups. Because we had only modest numbers of patients with a CS near the cutoff value (i.e., 4 or 5), we could not accurately estimate the annual mortality in such patients.
Information on other potentially useful parameters, such as peripheral arterial disease, carotid disease, and heart failure, was not available. Because these patients were studied before the introduction of gated SPECT, we could not assess the impact of ejection fraction measurements.
Another limitation is that we did not consider other exercise test findings to identify the low-risk group, including chronotropic incompetence (21), abnormal heart rate recovery (22), or ventricular ectopy (23). We used only the Duke treadmill score, which is based on exercise capacity, ST-segment depression, and exercise-induced angina (3). Recent work from our institution has suggested that exercise capacity is the only prognostically important component of the Duke treadmill score for prediction of mortality and cardiovascular events in the elderly (24).
Patients with a low CS may still have CAD (e.g., a 55-year-old male with typical angina but no diabetes or previous MI). Our results suggest that such a patient has a low risk of subsequent events if he or she has a low-risk treadmill score.
Conclusions. Despite these limitations, the results show that in symptomatic patients with low-risk Duke treadmill scores and high clinical risk, annual cardiac mortality (>1%) is not low, and myocardial perfusion imaging has independent prognostic value. Myocardial perfusion imaging may be a more appropriate initial stress test in patients with high clinical risk, but further studies are needed to assess this possibility.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. J. Gibbons, T. D. Miller, D. Hodge, L. Urban, P. A. Araoz, P. Pellikka, and R. B. McCully Application of Appropriateness Criteria to Stress Single-Photon Emission Computed Tomography Sestamibi Studies and Stress Echocardiograms in an Academic Medical Center J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Metz, M. Beattie, R. Hom, R. F. Redberg, D. Grady, and K. E. Fleischmann The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography: A Meta-Analysis J. Am. Coll. Cardiol., January 16, 2007; 49(2): 227 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman, R. Hachamovitch, L. J. Shaw, J. D. Friedman, S. W. Hayes, L. E.J. Thomson, D. S. Fieno, G. Germano, N. D. Wong, X. Kang, et al. Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Noninvasive Risk Stratification and a Conceptual Framework for the Selection of Noninvasive Imaging Tests in Patients with Known or Suspected Coronary Artery Disease J. Nucl. Med., July 1, 2006; 47(7): 1107 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Anand, E. Lim, A. Lahiri, and J. J. Bax The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects Eur. Heart J., April 2, 2006; 27(8): 905 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman, R. Hachamovitch, L. J. Shaw, J. D. Friedman, S. W. Hayes, L. E.J. Thomson, D. S. Fieno, G. Germano, P. Slomka, N. D. Wong, et al. Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease J. Nucl. Med., January 1, 2006; 47(1): 74 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Di Carli and R. Hachamovitch Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J. Am. Coll. Cardiol., January 4, 2005; 45(1): 50 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al. Highlights of the year in JACC 2004 J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153. [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons and P. A. Araoz The year in cardiac imaging J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1937 - 1944. [Full Text] [PDF] |
||||
![]() |
A. Abidov, R. Hachamovitch, A. Rozanski, S. W. Hayes, M. M. Santos, M. G. Sciammarella, I. Cohen, J. Gerlach, J. D. Friedman, G. Germano, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1062 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman, N. D. Wong, H. Gransar, R. Miranda-Peats, J. Dahlbeck, S. W. Hayes, J. D. Friedman, X. Kang, D. Polk, R. Hachamovitch, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography J. Am. Coll. Cardiol., August 18, 2004; 44(4): 923 - 930. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |